Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis

New post hoc analysis of IPF clinical trials suggests that treatment with pirfenidone slows the worsening of patient-reported breathlessness over 12 months versus placebo in patients with more advanced disease (GAP stage II/III or FVC <80%) http://bit.ly/2yJyUVT

Na minha lista:
書目詳細資料
發表在:Eur Respir J
Main Authors: Glassberg, Marilyn K., Wijsenbeek, Marlies S., Gilberg, Frank, Petzinger, Ute, Kirchgaessler, Klaus-Uwe, Albera, Carlo
格式: Artigo
語言:Inglês
出版: European Respiratory Society 2019
主題:
Agora
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766683/
https://ncbi.nlm.nih.gov/pubmed/31164431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00399-2019
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍